IMMUNIC, INC. - Common Stock (IMUX)

Historical Holders from Q2 2019 to Q4 2025

Type / Class: Equity / Common Stock
Symbol: IMUX on Nasdaq
Shares outstanding: 120,284,725
Price per share: $0.5337
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 42,691,219
Total reported value: $37,637,800
% of total 13F portfolios: 0%
Share change: -7,487,200
Value change: -$6,009,905
Avg buy value change: +0%
Avg sell value change: -0%
Number of holders: 61
Price from insider filings: $0.8347

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of IMMUNIC, INC. - Common Stock (IMUX) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
JANUS HENDERSON GROUP PLC	10%	+233%	$8,531,675	+$6,622,427	12,016,444	+347%	JANUS HENDERSON GROUP PLC	28 Nov 2025
Alyeska Investment Group, L.P.	9.4%	-5.5%	$9,918,000	+$1,555,199	11,250,000	+19%	Alyeska Investment Group, L.P.	30 Sep 2025
Nantahala Capital Management, LLC	10%		$9,039,380		10,634,565		Nantahala Capital Management, LLC	30 Jun 2025
683 Capital Management, LLC	9.9%		$10,528,102		10,634,446		683 CAPITAL MANAGEMENT, LLC	02 Aug 2025
Adage Capital Management, L.P.	10%	+422%	$7,309,338	+$6,333,814	10,479,337	+649%	Adage Capital Management, L.P.	30 Jun 2025
BIOTECHNOLOGY VALUE FUND L P	10%		$8,317,401		9,785,178		BVF PARTNERS L P/IL	30 Jun 2025
Aberdeen Group plc	8.6%		$8,161,502		8,243,941		Aberdeen Group plc	30 Jun 2025
Avidity Partners Management LP	4.8%	-18%	$4,143,001	-$807,898	4,699,411	-16%	Avidity Partners Management LP	30 Sep 2025
VANGUARD GROUP INC	4.4%		$3,531,387		3,923,763		The Vanguard Group	31 Dec 2024
Soleus Private Equity Fund III, L.P.	1.6%		$1,392,934		1,580,007		Soleus Capital Management, L.P.	30 Sep 2025
RTW INVESTMENTS, LP	1.1%		$924,086		1,026,762		RTW Investments, LP	31 Mar 2025
ARMISTICE CAPITAL, LLC	5%	-50%	$328,030	-$49,773	372,085	-13%	Armistice Capital, LLC	30 Sep 2025

As of 30 Sep 2025, IMMUNIC, INC. - Common Stock (IMUX) has 61 institutional shareholders filing 13F forms. They hold 42,691,219 shares. of 120,284,725 outstanding shares (35%) .

Top 25 institutional shareholders own 35% of the company.

Filer	Ownership	Nb Shares	Share Change %	Portfolio %	Holdings Value
Aberdeen Group plc	6.9%	8,243,941	0%	0.01%	$7,267,858
BVF INC/IL	6.4%	7,652,972	0%	0.27%	$6,746,860
Avidity Partners Management LP	3.9%	4,699,411	-16%	0.94%	$4,143,001
VANGUARD GROUP INC	3.6%	4,345,105	+5.3%	0%	$3,832,383
MORGAN STANLEY	2.6%	3,103,122	-14%	0%	$2,735,712
Focus Partners Wealth	2.1%	2,581,587	+1.5%	0%	$2,275,927
Laurion Capital Management LP	1.6%	1,882,162	-1.2%	0.23%	$1,659,314
Soleus Capital Management, L.P.	1.3%	1,580,007	-78%	0.07%	$1,392,934
ADAGE CAPITAL PARTNERS GP, L.L.C.	1.2%	1,398,600	0%	0%	$1,233,006
GEODE CAPITAL MANAGEMENT, LLC	0.86%	1,033,772	+6.1%	0%	$911,653
Ikarian Capital, LLC	0.76%	914,170	0%	0.18%	$805,932
BlackRock, Inc.	0.6%	725,743	+3.9%	0%	$639,815
CITADEL ADVISORS LLC	0.44%	535,083		0%	$471,729
MARSHALL WACE, LLP	0.44%	533,515	+967%	0%	$469,492
MILLENNIUM MANAGEMENT LLC	0.44%	530,470	+414%	0%	$467,662
RENAISSANCE TECHNOLOGIES LLC	0.33%	391,653	+196%	0%	$345,281
STATE STREET CORP	0.28%	331,945	0%	0%	$292,643
Squarepoint Ops LLC	0.23%	271,574		0%	$239,420
BOOTHBAY FUND MANAGEMENT, LLC	0.2%	240,873	0%	0.01%	$212,354
NORTHERN TRUST CORP	0.18%	211,347	-18%	0%	$186,323
JANE STREET GROUP, LLC	0.16%	195,331		0%	$172,204
GSA CAPITAL PARTNERS LLP	0.16%	192,923		0.01%	$170,000
Exome Asset Management LLC	0.14%	173,900		0.1%	$153,310
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.1%	115,000	0%	0%	$101,384
Virtu Financial LLC	0.09%	112,287		0.01%	$99,000

Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q4	10,000	$5,337				53.37%	1
2025 Q3	42,691,219	$37,637,800	-$6,009,905	$42,229	$112,433	88.16%	61
2025 Q2	50,178,419	$35,007,422	+$6,044,811	$12,416	$9,207	69.75%	55
2025 Q1	40,453,267	$44,092,350	-$10,908,224	$95,375	$1,240,965	109%	63
2024 Q4	51,078,929	$51,080,793	-$5,071,048	$310,900	$823,600	100%	65
2024 Q3	55,990,706	$92,402,857	+$4,082,992	$505,875	$165	165%	61
2024 Q2	55,825,550	$62,078,863	-$1,856,880	$298,146	$5,217	111%	57
2024 Q1	57,356,707	$75,746,429	+$55,507,141	$278,784	$792	132%	60
2023 Q4	15,053,342	$22,577,900	-$4,814,035	$287,400	$683,551	150%	48
2023 Q3	18,267,619	$26,851,561	-$3,476,639	$222,264	$14,406	147%	52
2023 Q2	20,191,368	$50,673,312	-$8,732,685	$362,695	$216,613	251%	62
2023 Q1	24,698,571	$36,797,274	+$3,207,790	$379,056	$4,023	149%	56
2022 Q4	23,902,583	$33,408,429	+$4,477,561	$366,520	$449,120	140%	56
2022 Q3	16,966,507	$53,607,794	-$3,014,898	$290,248	$1,252,000	316%	58
2022 Q2	17,750,419	$61,580,669	-$12,047,018	$1,194,000	$3,427,000	347%	61
2022 Q1	17,604,014	$198,924,802	+$44,418,632	$5,411,000	$10,632,000	1,130%	77
2021 Q4	13,709,674	$131,117,717	+$7,601,585		$641,000	957.02%	66
2021 Q3	12,872,644	$113,978,993	+$30,166,210	$0	$673,000	884.95%	66
2021 Q2	9,414,644	$115,422,222	-$1,376,618	$811,000	$1,046,000	1,226%	55
2021 Q1	9,296,231	$148,180,917	-$6,245,917	$752,000	$1,259,000	1,594%	58
2020 Q4	9,017,659	$137,884,642	+$12,983,212	$272,000	$2,046,000	1,529.06%	64
2020 Q3	8,545,770	$158,687,665	+$86,119,339	$410,000	$1,835,000	1,856.97%	63
2020 Q2	4,205,096	$51,006,563	+$24,949,309		$676,000	1,212%	46
2020 Q1	2,123,281	$12,844,030	+$114,567		$333,000	601.07%	14
2019 Q4	2,138,394	$20,743,048	+$6,193,886		$1,067,000	969.99%	13
2019 Q3	1,499,234	$14,992,920	-$480,103		$1,108,000	1,000%	17
2019 Q2	1,536,778	$17,625,202	+$17,623,037		$1,270,000	1,145.54%	20